Lazertinib in Pretreated Epidermal Growth Factor Receptor T790M-Mutated Advanced Non-small Cell Lung Cancer: A Real-World Multicenter Study

被引：0
|
作者：
Ahn, B-C. [1 ,2 ]
Kim, H. [2 ]
Lee, J. [2 ]
Lee, J. B. [2 ]
Hong, M. -H. [2 ]
Kim, H. R. [2 ]
Cho, B. C. [2 ]
Lim, S. M. [2 ]
机构：
[1] Natl Canc Ctr, Goyang Si, South Korea
[2] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Lazertinib; real-world data; T790M EGFR mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-47
引用
下载
收藏
页码：S659 / S660
页数：2
相关论文
共 50 条
  • [31] Osimertinib for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer patients with leptomeningeal metastases and different T790M status
    Xu, Haiyan
    Chen, Hengqi
    Kong, Jianxin
    Zhang, Ye
    Liu, Shan
    Yang, Guangjian
    Yang, Lu
    Wang, Yan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (11)
  • [32] Osimertinib in the treatment of leptomeningeal disease in T790M- negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report
    Chen, Julia
    Soudy, Hussein
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (03)
  • [33] Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer
    He, Chen
    Zheng, Lixia
    Xu, Yuzhong
    Liu, Ming
    Li, Yuanguang
    Xu, Jun
    CLINICA CHIMICA ACTA, 2013, 425 : 119 - 124
  • [34] EFFECT OF SIMVASTATIN ON GEFITINIB RESISTANCE IN NON-SMALL CELL LUNG CANCER WITH THE T790M MUTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR
    Kim, Hak R.
    Hwang, Ki-Eun
    Jeong, Eun-Taik
    RESPIROLOGY, 2013, 18 : 150 - 150
  • [35] Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Zhou, Yongchun
    Ma, Yuhui
    Shi, Hutao
    Du, Yaxi
    Huang, Yunchao
    SCIENTIFIC REPORTS, 2018, 8
  • [36] Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Yongchun Zhou
    Yuhui Ma
    Hutao Shi
    Yaxi Du
    Yunchao Huang
    Scientific Reports, 8
  • [37] Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer
    Inukai, Michio
    Toyooka, Shinichi
    Ito, Sachio
    Asano, Hiroaki
    Ichihara, Shuji
    Soh, Junichi
    Suehisa, Hiroshi
    Ouchida, Mamoru
    Aoe, Keisuke
    Aoe, Motoi
    Kiura, Katsuyuki
    Shimizu, Nobuyoshi
    Date, Hiroshi
    CANCER RESEARCH, 2006, 66 (16) : 7854 - 7858
  • [38] Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
    Fernandes, Maria Gabriela O.
    Sousa, Catarina
    Jacob, Maria
    Almeida, Leonor
    Santos, Vanessa
    Araujo, David
    Novais Bastos, Helder
    Magalhaes, Adriana
    Cirnes, Luis
    Moura, Conceicao Souto
    Queiroga, Henrique
    Cruz-Martins, Natalia
    Hespanhol, Venceslau
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan
    Cheng, Wen-Chien
    Shen, Yi-Cheng
    Chien, Chun-Ru
    Liao, Wei-Chih
    Chen, Chia-Hung
    Hsia, Te-Chun
    Tu, Chih-Yeh
    Chen, Hung-Jen
    THORACIC CANCER, 2022, 13 (10) : 1505 - 1512
  • [40] Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer
    Matsumoto, Yoshiya
    Kawaguchi, Tomoya
    Yamamoto, Norio
    Sawa, Kenji
    Yoshimoto, Naoki
    Suzumura, Tomohiro
    Watanabe, Tetsuya
    Mitsuoka, Shigeki
    Asai, Kazuhisa
    Kimura, Tatsuo
    Yoshimura, Naruo
    Kuwae, Yuko
    Hirata, Kazuto
    INTERNAL MEDICINE, 2017, 56 (17) : 2325 - 2328
12345